Endoscopic Gastric Remodeling and Its Histologic Impact on Metabolic Dysfunction-associated Steatohepatitis: A 12-month Prospective Study
{{output}}
Background and aims: Weight loss through lifestyle modification or GLP-1 receptor agonists (GLP-1RAs) is first-line therapy for metabolic dysfunction-associated steatohepatitis (MASH). However, few achieve sufficient weight loss ... ...
